© 2018 by Cardiac Revival Machines
Resources
Benefits of ICD
Long-Term benefit of Primary Prevention with an implantable Cardioverter-Defibrillator Our findings demonstrate a sustained 8-year survival benefit with primary ICD therapy in the MADIT-II population.ICD Longevity
ICD Manufacturers Must Increase Battery Life to Cut Cost , Improve Care Historically, ICD and CRT-D devices have needed to be replaced every three to seven years as the device's battery life deteriorates. Consequently, it is not unusual for patients to require several device replacements over their lifetime meaning additional costly procedures and increased risk of complications with each procedure. As the baby boomer population in the United States continues to age, and the average life expectancy in the United States increases to 76 years for men and 81 years for women, the number of patients who would benefit from a CRM device will grow exponentially. For the average patient whose CRT-D or ICD device lasts three to five years, this could result in two to four device charge-outs over their lifetime. Effect of Battery Longevity on Costs and Health Outcomes Associated with Cardiac Implantable Electronic Devices Based on modeling results, as battery longevity increases, patients experience fewer adverse outcomes and healthcare costs are reduced. Longevity of Implantable Cardioverter Defibrillators: Implications for Clinical Practice and Health Care Systems ICD longevity is the priority with respect to size not only for health systems, but also for the patients themselves. Longevity of Implantable Cardioverter Defibrillators, Influencing Factors, and Comparison to Industry-Projected Longevity Overall, ICD longevity is not quite satisfactory, as even the manufacturer with the best longevity barely reaches a median longevity of 7.5 years. Industry-projected longevity is an overestimation and does not accurately reflect real world longevity. Device companies and their engineers should concentrate all their efforts to improving battery performance. Based on limited experience with selected models, physicians know that longevity greater than 10 years is technically feasible. Impact of ICD Battery Longevity on Need for Device Replacements - Insight from a Veterans Affairs Database Increasing ICD longevity is an important target that will help to reduce patient risks related to replacements as well as to reduce costs. Outcome of advisory implantable cardioverter-defibrillator replacement: one-year follow-up. Complications from advisory ICD generator replacement are frequent and include infection and, rarely, death. The risk of replacement is increased in patients with multiple previous pocket procedures.
© Copyright 2018 by Cardiac Revival Machines
Resources
Benefits of ICD
Long-Term benefit of Primary Prevention with an implantable Cardioverter-Defibrillator Our findings demonstrate a sustained 8-year survival benefit with primary ICD therapy in the MADIT-II population.ICD Longevity
ICD Manufacturers Must Increase Battery Life to Cut Cost , Improve Care Historically, ICD and CRT-D devices have needed to be replaced every three to seven years as the device's battery life deteriorates. Consequently, it is not unusual for patients to require several device replacements over their lifetime meaning additional costly procedures and increased risk of complications with each procedure. As the baby boomer population in the United States continues to age, and the average life expectancy in the United States increases to 76 years for men and 81 years for women, the number of patients who would benefit from a CRM device will grow exponentially. For the average patient whose CRT-D or ICD device lasts three to five years, this could result in two to four device charge- outs over their lifetime. Effect of Battery Longevity on Costs and Health Outcomes Associated with Cardiac Implantable Electronic Devices Based on modeling results, as battery longevity increases, patients experience fewer adverse outcomes and healthcare costs are reduced. Longevity of Implantable Cardioverter Defibrillators: Implications for Clinical Practice and Health Care Systems ICD longevity is the priority with respect to size not only for health systems, but also for the patients themselves. Longevity of Implantable Cardioverter Defibrillators, Influencing Factors, and Comparison to Industry-Projected Longevity Overall, ICD longevity is not quite satisfactory, as even the manufacturer with the best longevity barely reaches a median longevity of 7.5 years. Industry-projected longevity is an overestimation and does not accurately reflect real world longevity. Device companies and their engineers should concentrate all their efforts to improving battery performance. Based on limited experience with selected models, physicians know that longevity greater than 10 years is technically feasible. Impact of ICD Battery Longevity on Need for Device Replacements - Insight from a Veterans Affairs Database Increasing ICD longevity is an important target that will help to reduce patient risks related to replacements as well as to reduce costs. Outcome of advisory implantable cardioverter- defibrillator replacement: one-year follow-up. Complications from advisory ICD generator replacement are frequent and include infection and, rarely, death. The risk of replacement is increased in patients with multiple previous pocket procedures.
